Home
Search
Search Results
Previously Searched
3105 results found
Expand All
Apply All
3105 results found

BIO stands with Dr. Fauci and science
Good Day BIO Newsletter  •  July 16, 2020
Today, we have a statement in support of Dr. Anthony Fauci, and scientists everywhere. We also take a look at a big deal for sustainable aviation fuel, and what it means for the future of the industry and the environment. Here’s your Thursday news in around 635 words, or 3 minutes. P.S. Today at noon ET, the Information Technology and Innovation Foundation (ITIF) will hold a free webinar on the role of biopharma startups in driving life sciences innovation during the COVID-19 pandemic, featuring BIO member Inovio. Click here to register.
Read More

Standing STRONGER against vaccine misinformation
Good Day BIO Newsletter  •  July 15, 2020
A new initiative is here to help you stand strong against vaccine misinformation. We’ve got the details, plus a look at how biotech could help eradicate African swine fever, in around 660 words, or 3 minutes, 18 seconds.
Read More

Your COVID vaccine questions, answered
Good Day BIO Newsletter  •  July 14, 2020
BIO leadership were in the news yesterday, answering some of your pressing questions about a coronavirus vaccine. More on that, plus a lot of links and what’s happening in Washington, in around 730 words, or 3 and a half minutes.
Read More

The other pandemic
Good Day BIO Newsletter  •  July 13, 2020
Following the launch of the AMR Action Fund last week, we have a timely episode of the I AM BIO Podcast featuring an antibiotic innovator on what needs to happen in order for us to beat antimicrobial resistance. We also take a look at another biotech innovator delivering clean fuels and clean jobs to the United States. Here are 787 words, just under 4 minutes.
Read More

New fund takes aim at antimicrobial resistance
Good Day BIO Newsletter  •  July 10, 2020
It’s a busy Friday. We’re taking a look at the new $1 billion industry initiative to support the antibiotic pipeline, as well as the details of the House GOP’s just-dropped tax package, which includes several benefits for drug developers. Here’s your news in around 860 words, just over 4 minutes.
Read More

BIO Signs Letter to Congress Urging More Relief for Agriculture Amid COVID-19
Agriculture & Environment, Food & Farm Innovation  •  Letters, Testimony & Comments  •  July 9, 2020
As Congress develops and debates additional bipartisan legislation in response to COVID-19 and the resulting impacts to workers and the economy, the economic losses persisting across U.S. agriculture must be addressed in the legislation and in future assistance provided by USDA. The economic losses across the U.S. agriculture sector are broad‐based, directly impacting farmers and ranchers and their supply chain partners – from input providers to end users. The widespread closures at the retail and food service levels are impacting consumer demand and purchasing patterns in ways that the industry has never experienced. The disruptions and logistical challenges in the supply chain are adding unprecedented costs and risks in the marketing system. USDA’s most recent World Agricultural Supply and Demand Estimates suggest that the decline in commodity value alone is nearly $50 billion. Much of this decline is attributable to COVID-19-related supply and demand destruction. This does not include all of agriculture’s losses which would be billions more. Moreover, millions of Americans are food insecure right now and are in need of critical nutrition assistance.  
Read More

Biopharmaceutical Leaders Announce New Effort to Tackle Superbugs, Spur Development of New Antibiotics
Press Release  •  July 9, 2020
Today more than 20 leading biopharmaceutical companies announced the creation of an estimated $1 billion fund to help support the pipeline for new antibiotic treatments. The AMR Action Fund was launched as the threat of antimicrobial resistance, or AMR, continues to grow and claim more lives. In response to today’s launch of the fund, BIO issued the following statements celebrating the news: “Antimicrobial resistance is one of the largest and looming public health threats we face today,” said BIO President and CEO Dr. Michelle McMurry-Heath. “Even as the world’s scientists work tirelessly to fight COVID-19, we must not ease up on our battle against antimicrobial resistance. Just as we’ve seen our industry step up during the pandemic, I applaud these biopharmaceutical leaders and partners for committing to the development of new antibiotics. The AMR Action Fund will provide critical support for the development of new medicines, but it is up to policymakers to enact the long-term changes needed to support healthy, sustainable markets for the future development of new and effective antibiotics.” “For years, we’ve watched antimicrobial-resistance infections rapidly rise around the world, while the market has slowly shrunk for new medicines to fight them,” said Greg Frank, Director of Infectious Disease Policy at BIO & Director of the Working to Fight AMR campaign. “Today’s new AMR Action Fund will have a tremendous impact on the development of new antimicrobials, but we still need government to implement new policies and incentives so companies can successfully develop, test, and launch new antimicrobial products.” Biopharmaceutical companies and foundations supporting the fund are: Almirall, Amgen, Bayer, Boehringer Ingelheim, Chugai, Daiichi Sankyo, Eisai, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, LEO Pharma, Lundbeck, Menarini, Merck, MSD, Novartis, Novo Nordisk, Novo Nordisk Foundation, Pfizer, Roche, Shionogi, Takeda, Teva, and UCB …
Read More

A resilient future starts with the biobased economy
Good Day BIO Newsletter  •  July 9, 2020
Today we take a deep dive into why the biobased economy will help us recover from this pandemic—and prepare for the next one. We also head to Ohio, where we testified in front of state health policymakers on the drug development process and the industry’s response to COVID-19. Here are 860 words, around 4 minutes, 18 seconds. P.S. Today, the Partnership to Improve Patient Care (PIPC) will hold a webinar at 11 AM ET on ICER’s COVID model. Click here to register.
Read More

BIO Impact Goes Fully Digital for 2020
Agriculture & Environment  •  Press Release  •  July 8, 2020
Washington, D.C. (July 8, 2020)—The Biotechnology Innovation Organization (BIO) announced today it will be moving the 2020 BIO IMPACT Ag & Environment Conference scheduled for September 21-22 to an online platform, instead of convening an in-person event. “Today out of an abundance of caution, we are announcing that the 2020 BIO Impact Ag and Environment Conference will be going fully digitial in September,” said Dr. Michelle McMurry-Heath, BIO President and CEO. "While we are disappointed that we will not be able to host BIO Impact in Raleigh, I am excited to build off the success of BIO Digital for this important event." Earlier this month, BIO convened a very successful BIO Digital event, in lieu of its in-person BIO International Convention. BIO IMPACT Digital will adopt many of the same formats. Taking place over two days, BIO IMPACT Digital will feature expert-level program content focused on the most pressing topics including climate change, sustainability, the bioeconomy, international development, and how COVID is impacting our industry’s work in each of these areas. Panels will be a mix of live and on-demand sessions. “There has never been a more important time to shine a light on the science that is truly making our world more resilient by improving our food security in sustainable ways, protecting our environment, and facilitating breakthroughs in green energy and biobased manufacturing," said McMurry-Heath.  BIO Impact Digital will also feature BIO’s One-on-One Partnering system, which allows attendees to schedule virtual meetings using their preferred methods –teleconference, video, or another medium – to maximize their business developing and partnering potential. In February, BIO renamed the BIO World Congress on Industrial Biotechnology to be the BIO Impact Ag & Environment Conference to better represent the influence biotech innovations have across the agriculture and environment sectors. Building on nearly two decades of…
Read More
BIO Impact

A big deal for Novavax
Good Day BIO Newsletter  •  July 8, 2020
Operation Warp Speed just announced its biggest deal yet, with BIO member Novavax. And we’ve announced BIO IMPACT Digital, our fully virtual conference for the ag and environment biotech industry. Here’s today’s news in 670 words, 3 minutes, 20 seconds. P.S. Join us tomorrow, Thursday, July 9, for the global launch of a new effort to address antimicrobial resistance. The event will feature policymakers and executives from Eli Lilly, Merck, and Pfizer, as well as a fireside chat with BIO’s Dr. Michelle McMurry-Heath and former NFL player Brandon Noble, who survived MRSA. Click here to register for the free event.
Read More